In melanocytic lesions the fraction of BRAFV600E alleles is associated with sun exposure but unrelated to ERK phosphorylation

Tiziana Venesio, Giovanna Chiorino, Antonella Balsamo, Alessandro Zaccagna, Consalvo Petti, Maria Scatolini, Alberto Pisacane, Ivana Sarotto, Franco Picciotto, Mauro Risio

Research output: Contribution to journalArticle

Abstract

BRAFV600E mutation has been frequently reported in different types of melanocytic lesions, but its role in melanomagenesis is poorly understood, having been associated with either the proliferative-induced MAPK pathway activation or the acquisition of oncogene-driven senescence. The presence of BRAF alterations has been related to sun exposure, although the molecular mechanisms underlying this event are only partly known. To elucidate the relationships among BRAF/NRAS alterations, MAPK pathway activation, and sun exposure, we examined 22 acquired nevi and 18 cutaneus melanomas from 38 patients. Microdissected tissues from each lesion were subjected to BRAF/NRAS mutation analysis by sequencing, allele-specific PCR and pyrosequencing assay. The same lesions were also examined for the expression of phosphorylated ERK1/2. Phototype and an accurate history of sun exposure were evaluated for each patient. BRAFV600E mutation was detected in 50% of the acquired nevi and in 70% of the cutaneus melanomas in the absence of NRAS alterations. The fraction of alleles carrying BRAFV600E substitution was variable but strongly associated with sun exposure. In contrast, no relationship was evidenced between the presence of this mutation and patients' phototype, phosphorylated ERK1/2 expression, or Clark's level. Our findings indicate that in melanocytic lesions, BRAFV600E mutation can affect a subset of the cells and is associated with the type and quantity of sun exposure. This mutation is independent of the nevo-melanoma progression and unrelated to ERK phosphorylation, suggesting that alternative mechanisms to the MAPK activation are also involved in this type of transformation.

Original languageEnglish
Pages (from-to)716-726
Number of pages11
JournalModern Pathology
Volume21
Issue number6
DOIs
Publication statusPublished - Jun 8 2008

Fingerprint

Solar System
Alleles
Phosphorylation
Mutation
Melanoma
Nevus
Oncogenes
Polymerase Chain Reaction

Keywords

  • Allelic fraction
  • BRAF
  • Phosphorylated ERK1/2
  • Sun exposure

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

In melanocytic lesions the fraction of BRAFV600E alleles is associated with sun exposure but unrelated to ERK phosphorylation. / Venesio, Tiziana; Chiorino, Giovanna; Balsamo, Antonella; Zaccagna, Alessandro; Petti, Consalvo; Scatolini, Maria; Pisacane, Alberto; Sarotto, Ivana; Picciotto, Franco; Risio, Mauro.

In: Modern Pathology, Vol. 21, No. 6, 08.06.2008, p. 716-726.

Research output: Contribution to journalArticle

@article{6d3f859038354752911f7609d8028fa2,
title = "In melanocytic lesions the fraction of BRAFV600E alleles is associated with sun exposure but unrelated to ERK phosphorylation",
abstract = "BRAFV600E mutation has been frequently reported in different types of melanocytic lesions, but its role in melanomagenesis is poorly understood, having been associated with either the proliferative-induced MAPK pathway activation or the acquisition of oncogene-driven senescence. The presence of BRAF alterations has been related to sun exposure, although the molecular mechanisms underlying this event are only partly known. To elucidate the relationships among BRAF/NRAS alterations, MAPK pathway activation, and sun exposure, we examined 22 acquired nevi and 18 cutaneus melanomas from 38 patients. Microdissected tissues from each lesion were subjected to BRAF/NRAS mutation analysis by sequencing, allele-specific PCR and pyrosequencing assay. The same lesions were also examined for the expression of phosphorylated ERK1/2. Phototype and an accurate history of sun exposure were evaluated for each patient. BRAFV600E mutation was detected in 50{\%} of the acquired nevi and in 70{\%} of the cutaneus melanomas in the absence of NRAS alterations. The fraction of alleles carrying BRAFV600E substitution was variable but strongly associated with sun exposure. In contrast, no relationship was evidenced between the presence of this mutation and patients' phototype, phosphorylated ERK1/2 expression, or Clark's level. Our findings indicate that in melanocytic lesions, BRAFV600E mutation can affect a subset of the cells and is associated with the type and quantity of sun exposure. This mutation is independent of the nevo-melanoma progression and unrelated to ERK phosphorylation, suggesting that alternative mechanisms to the MAPK activation are also involved in this type of transformation.",
keywords = "Allelic fraction, BRAF, Phosphorylated ERK1/2, Sun exposure",
author = "Tiziana Venesio and Giovanna Chiorino and Antonella Balsamo and Alessandro Zaccagna and Consalvo Petti and Maria Scatolini and Alberto Pisacane and Ivana Sarotto and Franco Picciotto and Mauro Risio",
year = "2008",
month = "6",
day = "8",
doi = "10.1038/modpathol.2008.41",
language = "English",
volume = "21",
pages = "716--726",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - In melanocytic lesions the fraction of BRAFV600E alleles is associated with sun exposure but unrelated to ERK phosphorylation

AU - Venesio, Tiziana

AU - Chiorino, Giovanna

AU - Balsamo, Antonella

AU - Zaccagna, Alessandro

AU - Petti, Consalvo

AU - Scatolini, Maria

AU - Pisacane, Alberto

AU - Sarotto, Ivana

AU - Picciotto, Franco

AU - Risio, Mauro

PY - 2008/6/8

Y1 - 2008/6/8

N2 - BRAFV600E mutation has been frequently reported in different types of melanocytic lesions, but its role in melanomagenesis is poorly understood, having been associated with either the proliferative-induced MAPK pathway activation or the acquisition of oncogene-driven senescence. The presence of BRAF alterations has been related to sun exposure, although the molecular mechanisms underlying this event are only partly known. To elucidate the relationships among BRAF/NRAS alterations, MAPK pathway activation, and sun exposure, we examined 22 acquired nevi and 18 cutaneus melanomas from 38 patients. Microdissected tissues from each lesion were subjected to BRAF/NRAS mutation analysis by sequencing, allele-specific PCR and pyrosequencing assay. The same lesions were also examined for the expression of phosphorylated ERK1/2. Phototype and an accurate history of sun exposure were evaluated for each patient. BRAFV600E mutation was detected in 50% of the acquired nevi and in 70% of the cutaneus melanomas in the absence of NRAS alterations. The fraction of alleles carrying BRAFV600E substitution was variable but strongly associated with sun exposure. In contrast, no relationship was evidenced between the presence of this mutation and patients' phototype, phosphorylated ERK1/2 expression, or Clark's level. Our findings indicate that in melanocytic lesions, BRAFV600E mutation can affect a subset of the cells and is associated with the type and quantity of sun exposure. This mutation is independent of the nevo-melanoma progression and unrelated to ERK phosphorylation, suggesting that alternative mechanisms to the MAPK activation are also involved in this type of transformation.

AB - BRAFV600E mutation has been frequently reported in different types of melanocytic lesions, but its role in melanomagenesis is poorly understood, having been associated with either the proliferative-induced MAPK pathway activation or the acquisition of oncogene-driven senescence. The presence of BRAF alterations has been related to sun exposure, although the molecular mechanisms underlying this event are only partly known. To elucidate the relationships among BRAF/NRAS alterations, MAPK pathway activation, and sun exposure, we examined 22 acquired nevi and 18 cutaneus melanomas from 38 patients. Microdissected tissues from each lesion were subjected to BRAF/NRAS mutation analysis by sequencing, allele-specific PCR and pyrosequencing assay. The same lesions were also examined for the expression of phosphorylated ERK1/2. Phototype and an accurate history of sun exposure were evaluated for each patient. BRAFV600E mutation was detected in 50% of the acquired nevi and in 70% of the cutaneus melanomas in the absence of NRAS alterations. The fraction of alleles carrying BRAFV600E substitution was variable but strongly associated with sun exposure. In contrast, no relationship was evidenced between the presence of this mutation and patients' phototype, phosphorylated ERK1/2 expression, or Clark's level. Our findings indicate that in melanocytic lesions, BRAFV600E mutation can affect a subset of the cells and is associated with the type and quantity of sun exposure. This mutation is independent of the nevo-melanoma progression and unrelated to ERK phosphorylation, suggesting that alternative mechanisms to the MAPK activation are also involved in this type of transformation.

KW - Allelic fraction

KW - BRAF

KW - Phosphorylated ERK1/2

KW - Sun exposure

UR - http://www.scopus.com/inward/record.url?scp=44349127222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44349127222&partnerID=8YFLogxK

U2 - 10.1038/modpathol.2008.41

DO - 10.1038/modpathol.2008.41

M3 - Article

C2 - 18408659

AN - SCOPUS:44349127222

VL - 21

SP - 716

EP - 726

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 6

ER -